Dyax Corp. (NASDAQ:DYAX) announced today that executive management will participate in the 2014 Leerink Global Healthcare Conference being held February 12-13, 2014 at the Waldorf Astoria in New York City. On Wednesday, February 12 at 11:05AM (ET), Gustav Christensen, President and Chief Executive Officer, will participate in a fireside chat to discuss the Company’s key value drivers – the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Portfolio.
This presentation will be webcast live and may be accessed by visiting the Investor Relations section of the company website at www.dyax.com. The webcast will also be available on the Dyax website for a limited period of time following the conference.
Dyax, the Dyax logo and KALBITOR are registered marks of Dyax Corp.